Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation

凝血病 医学 止血 弥漫性血管内凝血 纤溶亢进 败血症 纤溶 重症监护医学 免疫学 内科学
作者
Toshiaki Iba,Julie Helms,Matthew D. Neal,Jerrold H. Levy
出处
期刊:Journal of Thrombosis and Haemostasis [Wiley]
卷期号:21 (12): 3360-3370 被引量:1
标识
DOI:10.1016/j.jtha.2023.05.028
摘要

Disseminated intravascular coagulation can occur due to different causes but commonly following sepsis. Trauma-induced coagulopathy (TIC) occurs on hospital arrival in approximately 25% of seriously injured patients who initially presents with impaired hemostasis and a bleeding phenotype that can later progress to a prothrombotic phase. Following traumatic injury, ineffective hemostasis is driven by massive blood loss, tissue damage, and hyperfibrinolysis. This initial impaired hemostasis continues until surgical or other management strategies not only to stop the causes of hemorrhage but also progresses to a prothrombotic and hypofibrinolytic state, also termed fibrinolytic shutdown. Prothrombotic progression is also promoted by inflammatory mediator release, endothelial injury, and platelet dysregulation, which is commonly seen in sepsis with increased mortality. Unlike TIC, the early phase of sepsis is frequently complicated by multiorgan dysfunction described as sepsis-induced coagulopathy (SIC) that lacks a hemorrhagic phase. The phenotypes of SIC and TIC are different, especially in their initial presentations; however, patients who survive TIC may also develop subsequent infections and potentially sepsis and SIC. Although the pathophysiology of SIC and TIC are different, endothelial injury, dysregulated fibrinolysis, and coagulation abnormalities are common. Management includes treatment of the underlying cause, tissue injury vs infection is critical, and supportive therapies, such as hemostatic resuscitation and circulatory support are essential, and adjunct therapies are recommended in guidelines. Based on clinical studies and certain guidelines, additional therapies include tranexamic acid in the limited timing of initial traumatic injury and anticoagulants, such as antithrombin and recombinant thrombomodulin in disseminated intravascular coagulation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
4秒前
orixero应助勤劳三问采纳,获得10
4秒前
乔雨安完成签到,获得积分20
5秒前
肉肉儿发布了新的文献求助10
8秒前
JIE发布了新的文献求助30
8秒前
拂晓发布了新的文献求助10
9秒前
10秒前
隐形曼青应助席香薇采纳,获得10
13秒前
物质尽头完成签到,获得积分10
13秒前
14秒前
15秒前
kekele发布了新的文献求助10
17秒前
19秒前
李健应助科研通管家采纳,获得10
19秒前
20秒前
肉肉儿完成签到,获得积分10
20秒前
科研通AI2S应助重要的溪流采纳,获得10
21秒前
欣喜的手机完成签到,获得积分10
21秒前
21秒前
酷酷忆灵发布了新的文献求助10
21秒前
21秒前
Yyy发布了新的文献求助10
23秒前
科研通AI2S应助cherish采纳,获得10
23秒前
汉堡包应助悲伤晴天雨采纳,获得10
24秒前
勤劳三问发布了新的文献求助10
25秒前
科研通AI2S应助宋晓蓝采纳,获得10
26秒前
122发布了新的文献求助10
26秒前
畅快安白完成签到,获得积分10
27秒前
27秒前
JamesPei应助lemon采纳,获得10
28秒前
29秒前
yiyu应助Yyy采纳,获得10
29秒前
czz完成签到,获得积分10
29秒前
30秒前
小蘑菇应助122采纳,获得10
37秒前
wanci应助122采纳,获得10
37秒前
大模型应助122采纳,获得10
37秒前
斯文败类应助122采纳,获得10
37秒前
Owen应助122采纳,获得10
37秒前
高分求助中
【本贴是提醒信息,请勿应助】请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 800
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
Challenges, Strategies, and Resiliency in Disaster and Risk Management 500
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2481718
求助须知:如何正确求助?哪些是违规求助? 2144343
关于积分的说明 5469502
捐赠科研通 1866838
什么是DOI,文献DOI怎么找? 927847
版权声明 563039
科研通“疑难数据库(出版商)”最低求助积分说明 496404